ResultsBusinessLine
Divi's Labs hits 52-week high on record Q2
GreyOak summary
Divi's Laboratories shares surged to a 52-week high of ₹11,824 following record Q2 results where revenue and EBITDA beat estimates. Brokerages upgraded the stock, with Goldman Sachs raising targets, while Airtel dipped 1.2% and Tata Steel slid 2.75% on mixed analyst views.
What it affects
- Divi's LaboratoriesDIVISLABPositive +42
Stock hit 52-week high on record Q2 resultsRolling sentiment Positive +80
Source
Read the original at BusinessLineMore Divi's Laboratories news
- Buy, Sell Or Hold: Divi's Labs, Tata Power, Kalyan Jewellers, Reliance Industries, L&T And Shriram Finance — Ask ProfitNDTV Profit · Stock view ·
- Scaling up of projects to drive gains for Divi's Labs amid strong Q2 showBusiness Standard · Results ·
- Divi's Market Cap Crosses Rs 3 Lakh CroreNDTV Profit · Company update ·
- Divi's shares jump 4% on 64% profit riseMoneycontrol · Results ·
- Pharma shares shine: Sai, Gland, Divi's, Laurus, Glenmark surge up to 9%Business Standard · Stock view ·